Xlife Sciences AG (XLS) — Capital Reinvestment Ratio
Latest as of December 2023:
0.24x
Xlife Sciences AG (XLS) has a Capital Reinvestment Ratio of 0.24x as of December 2023, meaning it reinvests 0% of its operating cash flow (CHF171.78K) in capital expenditures (CHF41.08K). See XLS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.24x
Capex / Operating Cash Flow
Operating Cash Flow
CHF171.78K
CHF
Capital Expenditures
CHF41.08K
CHF
Data as of
Dec 2023
Most recent filing
Xlife Sciences AG Capital Reinvestment Ratio (2023–2023)
This chart tracks Xlife Sciences AG's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Xlife Sciences AG (2023–2023)
Year-by-year Capital Reinvestment Ratio for Xlife Sciences AG from 2023 to 2023. For live market cap and broader valuation context, see Xlife Sciences AG stock valuation.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.24x | CHF171.78K | CHF41.08K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow